BTLA and ovarian cancer: Additionally, the study beyond miR-155, demonstrated that miR-32, one of the downregulated miRNAs in ovarian cancer, exerts inhibitory effects on the proliferation, migration, and invasion of ovarian cancer cells by targeting BTLA [51].